Literature DB >> 25685869

Cystinuria: current concepts and future directions.

Daniel J Castro Pereira1, Anton C Schoolwerth, Vernon M Pais.   

Abstract

Cystinuria, an autosomic recessive genetic disorder is an uncommon cause of nephrolithiasis characterized by an impairment of transport of cystine, ornithine, lysine, and arginine (COLA). Of these, only cystine is insoluble enough to cause stone formation. Although a classification exists that categorizes the disease depending on chromosomal mutation, this does not currently alter management which consists of increased fluid intake, urine alkalinization, reduced sodium intake and, if warranted, cystine-binding thiol drugs. Cystine stones are relatively resistant to fragmentation. Intrinsic characteristics on imaging may help in planning surgical treatment. Finally, advances in crystal growth inhibition are encouraging as they may provide a new tool to treat this condition which although uncommon, is treatable and has been associated with lower quality of life and renal function compared to other stone formers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25685869     DOI: 10.5414/cn108514

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  10 in total

Review 1.  Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Authors:  Amrik Sahota; Jay A Tischfield; David S Goldfarb; Michael D Ward; Longqin Hu
Journal:  Urolithiasis       Date:  2018-12-04       Impact factor: 3.436

2.  Design, synthesis, and evaluation of l-cystine diamides as l-cystine crystallization inhibitors for cystinuria.

Authors:  Yanhui Yang; Haifa Albanyan; Sumi Lee; Herve Aloysius; Jian-Jie Liang; Vladyslav Kholodovych; Amrik Sahota; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2018-03-10       Impact factor: 2.823

3.  Educational Case: Urinary Stones.

Authors:  Ryan L Frazier; Alison R Huppmann
Journal:  Acad Pathol       Date:  2021-09-03

4.  Metabolic consequences of cystinuria.

Authors:  Lauren E Woodard; Richard C Welch; Ruth Ann Veach; Thomas M Beckermann; Feng Sha; Edward J Weinman; Talat Alp Ikizler; Jay A Tischfield; Amrik Sahota; Matthew H Wilson
Journal:  BMC Nephrol       Date:  2019-06-20       Impact factor: 2.388

Review 5.  Amino Acid Transport Defects in Human Inherited Metabolic Disorders.

Authors:  Raquel Yahyaoui; Javier Pérez-Frías
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

Review 6.  Cystinuria: Review of a Life-long and Frustrating Disease.

Authors:  Nicholas S Kowalczyk; Anna L Zisman
Journal:  Yale J Biol Med       Date:  2021-12-29

Review 7.  Cystinuria: An Overview of Challenges and Surgical Management.

Authors:  Calum Stephen Clark; Sanjith Gnanappiragasam; Kay Thomas; Matthew Bultitude
Journal:  Front Surg       Date:  2022-06-16

8.  Global Prioritization of Disease Candidate Metabolites Based on a Multi-omics Composite Network.

Authors:  Qianlan Yao; Yanjun Xu; Haixiu Yang; Desi Shang; Chunlong Zhang; Yunpeng Zhang; Zeguo Sun; Xinrui Shi; Li Feng; Junwei Han; Fei Su; Chunquan Li; Xia Li
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

9.  Potassium Citrate is Better in Reducing Salt and Increasing Urine pH than Oral Intake of Lemonade: A Cross-Over Study.

Authors:  Jing Shen; Xicheng Zhang
Journal:  Med Sci Monit       Date:  2018-04-01

10.  Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.

Authors:  Xiaoguang Liu; Kellen Olszewski; Yilei Zhang; Esther W Lim; Jiejun Shi; Xiaoshan Zhang; Jie Zhang; Hyemin Lee; Pranavi Koppula; Guang Lei; Li Zhuang; M James You; Bingliang Fang; Wei Li; Christian M Metallo; Masha V Poyurovsky; Boyi Gan
Journal:  Nat Cell Biol       Date:  2020-03-30       Impact factor: 28.824

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.